SmartMoneyDB

BAKER BROS. ADVISORS LP

NEW YORK, NY · CIK 0001263508

Portfolio Value: $26.54B
Positions: 126
Period: 2020-12-31
Filed: 2021-02-16

Portfolio Value

$26.54B

Positions

126

New

11

Increased

20

Decreased

60

Sold Out

213

BAKER BROS. ADVISORS LP Q4 2020 13F Filing Summary

BAKER BROS. ADVISORS LP (NEW YORK, NY) reported a portfolio value of $26.54B across 126 positions in their Q4 2020 SEC 13F filing (period ending 2020-12-31). Top holdings include SE ($8.28B), ONC ($3.02B), INCY ($2.78B). The top 10 positions account for 84.2% of the portfolio. This quarter saw 11 new positions, 20 increases, 60 reductions, 213 complete exits. Notable new buys: ABCL ($420.51M), ALGS ($44.52M), THCH ($37.11M). Notable exits: NBIX, MyoKardia, Inc., EXAS.

All Holdings

#StockValueWeightChange
1
SESeagen Inc.
COM
$8.28B
31.19%
-
2
ONCBeiGene, Ltd.
SPONSORED ADR
$3.02B
11.36%
-12.3%
3
INCYIncyte Corporation
COM
$2.78B
10.49%
+0.0%
4
ACADACADIA Pharmaceuticals Inc.
COM
$2.24B
8.44%
-
5
KODKodiak Sciences Inc.
COM
$2.04B
7.68%
+12.4%
6
Alexion Pharmaceuticals, Inc.
COM
$1.37B
5.16%
-
7
PRLDPrelude Therapeutics Incorporated
COM
$723.99M
2.73%
-
8
BMRNBioMarin Pharmaceutical Inc.
COM
$665.50M
2.51%
-
9
Invitae Corporation
COM
$654.29M
2.46%
+32.0%
10
ASNDAscendis Pharma A/S
SPONSORED ADR
$590.45M
2.22%
-
11
ABCLAbCellera Biologics Inc.
COM
$420.51M
1.58%
New
12
ATIMirati Therapeutics, Inc.
COM
$309.64M
1.17%
-
13
ARGXargenx SE
SPONSORED ADR
$299.84M
1.13%
-
14
IGMSIGM Biosciences, Inc.
COM
$277.66M
1.05%
+0.0%
15
MDGLMadrigal Pharmaceuticals, Inc.
COM
$166.67M
0.63%
-
16
AMRNAmarin Corporation plc
SPONSORED ADR
$136.88M
0.52%
-12.6%
17
HRTXHeron Therapeutics, Inc.
COM
$126.88M
0.48%
-
18
KYMRKymera Therapeutics, Inc.
COM
$121.47M
0.46%
-
19
ALLKAllakos Inc.
COM
$100.00M
0.38%
+2.3%
20
CERSCerus Corporation
COM
$94.89M
0.36%
-
21
BCRXBioCryst Pharmaceuticals, Inc.
COM
$94.58M
0.36%
-
22
PACBPacific Biosciences of California, Inc.
COM
$83.06M
0.31%
-1.5%
23
ZYMEZymeworks Inc.
COM
$80.74M
0.30%
-
24
INSMInsmed Incorporated
COM PAR $.01
$71.77M
0.27%
-5.1%
25
THCHForma Therapeutics Holdings, Inc.
SHS
$70.67M
0.27%
+14.3%
26
RYTMRhythm Pharmaceuticals, Inc.
COM
$68.82M
0.26%
-6.3%
27
NBIXNeurocrine Biosciences, Inc.
COM
$64.89M
0.24%
-
28
AXSMAxsome Therapeutics, Inc.
COM
$63.45M
0.24%
-18.9%
29
RAREUltragenyx Pharmaceutical Inc.
COM
$61.52M
0.23%
+0.0%
30
NRIXNurix Therapeutics, Inc.
COM
$58.82M
0.22%
-
31
Atreca, Inc.
CL A COM
$57.05M
0.21%
-
32
THCHNeoleukin Therapeutics, Inc.
COM
$53.89M
0.20%
-
33
ADAPAdaptimmune Therapeutics plc
SPONSORED ADR
$52.99M
0.20%
+55.3%
34
APLSApellis Pharmaceuticals, Inc.
COM
$51.28M
0.19%
-
35
KNSAKiniksa Pharmaceuticals, Ltd.
COM CL A
$49.47M
0.19%
-
36
ADCTADC Therapeutics SA
SHS
$45.39M
0.17%
-16.0%
37
ALGSAligos Therapeutics, Inc.
COM
$44.52M
0.17%
New
38
THCHHorizon Therapeutics Public Ltd Co
SHS
$43.83M
0.17%
-10.1%
39
KRYSKrystal Biotech, Inc.
COM
$41.93M
0.16%
-9.8%
40
ChemoCentryx, Inc.
COM
$40.66M
0.15%
-27.0%
41
THCHGlobal Blood Therapeutics, Inc.
COM
$39.86M
0.15%
-
42
DBV Technologies S.A.
SPONSORED ADR
$38.29M
0.14%
-
43
THCHOpthea Limited
SPONSORED ADS
$37.11M
0.14%
New
44
MRUSMerus N.V.
COM
$35.72M
0.13%
-
45
ALKSAlkermes plc
SHS
$30.63M
0.12%
+13.0%
46
THCHFrequency Therapeutics, Inc.
COM
$30.20M
0.11%
-9.8%
47
PTGXProtagonist Therapeutics, Inc.
COM
$28.95M
0.11%
-10.0%
48
BCABBioAtla, Inc.
COM
$28.06M
0.11%
New
49
Reata Pharmaceuticals, Inc.
CL A
$27.69M
0.10%
+321.1%
50
ATHAAthira Pharma, Inc.
COM
$27.62M
0.10%
-8.6%
Showing 1-50 of 126

Position Changes

StockValueShares
ABCLAbCellera Biologics Inc.
$420.51M10,450,180
ALGSAligos Therapeutics, Inc.
$44.52M1,610,000
THCHOpthea Limited
$37.11M3,308,705
BCABBioAtla, Inc.
$28.06M825,000
VSTMVerastem, Inc.
$21.61M10,144,039
MREOMereo BioPharma Group plc
$21.59M6,030,293
THCHChinook Therapeutics, Inc.
$11.87M748,693
THCHSilverback Therapeutics, Inc.
$11.03M238,095
GOSSGossamer Bio, Inc.
$4.65M480,729
THCHLogicBio Therapeutics, Inc.
$3.44M451,478
Sunesis Pharmaceuticals, Inc.
$106.00K53,066